Evidence map›Paper›PMID 28779157›Full record

ArticleScientific reports2017

Cell Dispersal Influences Tumor Heterogeneity and Introduces a Bias in NGS Data Interpretation.

Lőrinc Pongor, Hajnalka Harami-Papp, Előd Méhes, András Czirók, Balázs Győrffy

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Immunotherapeutic Approaches in Ovarian Cancer.Current issues in molecular biology · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lőrinc PongorMTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary.ORCID 0000-0001-5917-4628
Hajnalka Harami-PappMTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary.
Előd MéhesDepartment of Biological Physics, Eötvös Loránd University, Budapest, Hungary.
András CzirókDepartment of Biological Physics, Eötvös Loránd University, Budapest, Hungary.ORCID 0000-0002-2694-5163
Balázs GyőrffyMTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary. gyorffy.balazs@ttk.mta.hu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Short and long distance cell dispersal can have a marked effect on tumor structure, high cellular motility could lead to faster cell mixing and lower observable intratumor heterogeneity. Here we evaluated a model for cell mixing that investigates how short-range dispersal and cell turnover will account for mutational proportions. We show that cancer cells can penetrate neighboring and distinct areas in a matter of days. In next generation sequencing runs, higher proportions of a given cell line generated frequencies with higher precision, while mixtures with lower amounts of each cell line had lower precision manifesting in higher standard deviations. When multiple cell lines were co-cultured, cellular movement altered observed mutation frequency by up to 18.5%. We propose that some of the shared mutations detected at low allele frequencies represent highly motile clones that appear in multiple regions of a tumor owing to dispersion throughout the tumor. In brief, cell movement will lead to a significant technical (sampling) bias when using next generation sequencing to determine clonal composition. A possible solution to this drawback would be to radically decrease detection thresholds and increase coverage in NGS analyses.

Indexed as

Genetic HeterogeneityGenetic VariationCell Line, TumorCell MovementComputational BiologyDisease ProgressionGenotypeHigh-Throughput Nucleotide SequencingHumansMutationNeoplasm InvasivenessNeoplasm MetastasisNeoplasms

Identifiers

PMID28779157
PMCPMC5544774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.